W Nowaczynski

2.4k total citations
98 papers, 1.8k citations indexed

About

W Nowaczynski is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W Nowaczynski has authored 98 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W Nowaczynski's work include Hormonal Regulation and Hypertension (63 papers), Hormonal and reproductive studies (25 papers) and Blood Pressure and Hypertension Studies (15 papers). W Nowaczynski is often cited by papers focused on Hormonal Regulation and Hypertension (63 papers), Hormonal and reproductive studies (25 papers) and Blood Pressure and Hypertension Studies (15 papers). W Nowaczynski collaborates with scholars based in Canada, United States and Japan. W Nowaczynski's co-authors include Jacques Genest, Otto Kuchel, Erich Köiw, R. Boucher, Franz H. Messerli, Roger Boucher, Pierre Biron, Masashi Honda, Jack G. Silah and Gordon P. Guthrie and has published in prestigious journals such as Science, New England Journal of Medicine and Circulation.

In The Last Decade

W Nowaczynski

95 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Nowaczynski Canada 23 905 376 334 260 188 98 1.8k
Bruce A. Scoggins Australia 20 733 0.8× 337 0.9× 277 0.8× 169 0.7× 159 0.8× 115 1.6k
J C Melby United States 20 633 0.7× 162 0.4× 240 0.7× 209 0.8× 165 0.9× 55 1.3k
P. Vecsei Germany 17 749 0.8× 423 1.1× 455 1.4× 124 0.5× 179 1.0× 86 1.5k
P F Semple United Kingdom 23 454 0.5× 569 1.5× 325 1.0× 268 1.0× 192 1.0× 75 1.4k
J. J. Brown United Kingdom 24 514 0.6× 595 1.6× 319 1.0× 355 1.4× 259 1.4× 68 1.5k
O. B. Holland United States 26 1.1k 1.2× 639 1.7× 414 1.2× 281 1.1× 521 2.8× 76 2.4k
C. I. Johnston Australia 25 388 0.4× 946 2.5× 425 1.3× 272 1.0× 171 0.9× 59 1.8k
R. Boucher Canada 27 724 0.8× 997 2.7× 830 2.5× 388 1.5× 238 1.3× 96 2.4k
E D Vaughan United States 21 357 0.4× 491 1.3× 385 1.2× 517 2.0× 282 1.5× 37 1.6k
M. J. Smith United States 16 443 0.5× 596 1.6× 247 0.7× 255 1.0× 133 0.7× 32 1.4k

Countries citing papers authored by W Nowaczynski

Since Specialization
Citations

This map shows the geographic impact of W Nowaczynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Nowaczynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Nowaczynski more than expected).

Fields of papers citing papers by W Nowaczynski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Nowaczynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Nowaczynski. The network helps show where W Nowaczynski may publish in the future.

Co-authorship network of co-authors of W Nowaczynski

This figure shows the co-authorship network connecting the top 25 collaborators of W Nowaczynski. A scholar is included among the top collaborators of W Nowaczynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Nowaczynski. W Nowaczynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nowaczynski, W, et al.. (1988). Plasma cortisol and corticosteroid-binding globulin in essential hypertension.. PubMed. 6(2). 82–94. 3 indexed citations
2.
Nowaczynski, W, et al.. (1985). Serum aldosterone and protein-binding variables in Yanomama Indians: a no-salt culture as compared to partially acculturated Guaymi Indians.. PubMed. 3(6). 289–306. 19 indexed citations
3.
Nowaczynski, W, et al.. (1983). Aldosterone-binding globulin-induced hypertension in the rat. A new experimental model.. Hypertension. 5(6_pt_3). V163–71. 2 indexed citations
4.
Nowaczynski, W, Franz H. Messerli, Otto Kuchel, Gordon P. Guthrie, & Jacques Genest. (1977). Origin of Urinary 16β-Hydroxydehydroepiandrosterone in Essential Hypertension. The Journal of Clinical Endocrinology & Metabolism. 44(4). 629–638. 7 indexed citations
5.
Guthrie, Gordon P., Jacques Genest, W Nowaczynski, R. Boucher, & Otto Kuchel. (1976). Dissociation of Plasma Renin Activity and Aldosterone in Essential Hypertension. The Journal of Clinical Endocrinology & Metabolism. 43(2). 446–448. 16 indexed citations
6.
Nowaczynski, W, et al.. (1976). Plasma deoxycorticosterone and aldosterone in essential hypertension. Journal of Steroid Biochemistry. 7(8). 565–569. 8 indexed citations
7.
Messerli, Franz H., Otto Kuchel, W Nowaczynski, et al.. (1976). Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.. Circulation. 53(3). 406–410. 19 indexed citations
8.
Kuchel, Otto, et al.. (1973). A dissociated effect of Amino-Glutethimide on the mineralocorticoid secretion in man. Metabolism. 22(2). 123–132. 13 indexed citations
9.
Nowaczynski, W, et al.. (1972). Plasma Progesterone in Normal Subjects and Patients with Benign Essential Hypertension on Normal, Low, and High Sodium Intake1. The Journal of Clinical Endocrinology & Metabolism. 34(4). 650–660. 7 indexed citations
10.
Genest, Jacques & W Nowaczynski. (1970). Aldosterone and Electrolyte Balance in Human Hypertension. Journal of the Royal College of Physicians of London. 5(1). 77–86. 13 indexed citations
11.
Nowaczynski, W, et al.. (1969). Evidence of in Vivo Inhibition of 11β-Hydroxylation of Steroids by Dehydroepiandrosterone in the Dog1. Endocrinology. 84(1). 98–103. 15 indexed citations
12.
Barbeau, André, et al.. (1969). Renin-Aldosterone System in Parkinson's Disease. Science. 165(3890). 291–292. 56 indexed citations
13.
Biron, Pierre, et al.. (1961). THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE*. Journal of Clinical Investigation. 40(2). 338–347. 147 indexed citations
14.
Sandor, Thomas, W Nowaczynski, & Jacques Genest. (1960). THE METABOLISM OF ALDOSTERONE BY SURVIVING DOG AND HUMAN LIVER SLICES. Canadian Journal of Biochemistry and Physiology. 38(1). 739–756. 1 indexed citations
15.
Nowaczynski, W, et al.. (1958). ISOLATION OF A STEROID-LIKE SUBSTANCE FROM URINE AND CITROUS FRUITS. Canadian Journal of Biochemistry and Physiology. 36(8). 869–881. 3 indexed citations
16.
Nowaczynski, W & Erich Köiw. (1957). A new paper chromatographic system for the separation of polar corticosteroids.. PubMed. 49(5). 815–8. 11 indexed citations
17.
Nowaczynski, W, et al.. (1956). FURTHER STUDIES ON THE ABSORPTION SPECTRA OF STEROIDS IN "100%" PHOSPHORIC ACID. Canadian Journal of Biochemistry and Physiology. 34(1). 592–599. 8 indexed citations
18.
Nowaczynski, W, et al.. (1956). FURTHER STUDIES ON THE ABSORPTION SPECTRA OF STEROIDS IN "100%" PHOSPHORIC ACID. Canadian Journal of Biochemistry and Physiology. 34(3). 592–599. 7 indexed citations
19.
Genest, Jacques, et al.. (1956). Human Arterial Hypertension: a State of Mild Chronic Hyperaldosteronism?. Science. 123(3195). 503–505. 71 indexed citations
20.
Nowaczynski, W, et al.. (1956). DETAILED STUDY OF A PURIFIED URINARY ALDOSTERONE FRACTION. Canadian Journal of Biochemistry and Physiology. 34(5). 1023–1038. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce A. Scoggins Breakdown of academic impact, for papers by J C Melby Breakdown of academic impact, for papers by P. Vecsei Breakdown of academic impact, for papers by P F Semple Breakdown of academic impact, for papers by J. J. Brown Breakdown of academic impact, for papers by O. B. Holland Breakdown of academic impact, for papers by C. I. Johnston Breakdown of academic impact, for papers by R. Boucher Breakdown of academic impact, for papers by E D Vaughan Breakdown of academic impact, for papers by M. J. Smith
Rankless by CCL
2026